Concise SAR Exploration Based on the "Head-to-Tail" Approach: Discovery of PI4KIIIα Inhibitors Bearing Diverse Scaffolds.
Identifieur interne : 002D23 ( Ncbi/Checkpoint ); précédent : 002D22; suivant : 002D24Concise SAR Exploration Based on the "Head-to-Tail" Approach: Discovery of PI4KIIIα Inhibitors Bearing Diverse Scaffolds.
Auteurs : Satoru Noji [Japon] ; Noriyoshi Seki [Japon] ; Takaki Maeba [Japon] ; Takayuki Sakai [Japon] ; Eiichi Watanabe [Japon] ; Katsuya Maeda [Japon] ; Kyoko Fukushima [Japon] ; Toru Noguchi [Japon] ; Kazuya Ogawa [Japon] ; Yukiyo Toyonaga [Japon] ; Tamotsu Negoro [Japon] ; Hisashi Kawasaki [Japon] ; Makoto Shiozaki [Japon]Source :
- ACS medicinal chemistry letters [ 1948-5875 ] ; 2016.
Abstract
In typical kinase inhibitor programs, a hinge binder showing best potency with preferential specificity is initially selected, followed by fine-tuning of the accompanying substituents on its core module. A shortcoming of this approach is that the exclusive focus on a single chemotype can endanger all the analogues in the series if a critical shortcoming is revealed. Thus, an early evaluation of structure-activity relationships (SARs) can mitigate unforeseen outcomes within a series of multiple compounds, although there have been very few examples to follow such a policy. PI4KIIIα is one of four mammalian phosphatidylinositol-4 kinases and has recently drawn significant attention as an emerging target for hepatitis C virus (HCV) treatment. In this letter, a novel "head-to-tail" approach to discover a diverse set of PI4KIIIα inhibitors is reported. We believe this method will generate distinct core scaffolds, a rational strategy to circumvent potential risks in general kinase programs.
DOI: 10.1021/acsmedchemlett.6b00232
PubMed: 27774129
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000B98
- to stream PubMed, to step Curation: 000B98
- to stream PubMed, to step Checkpoint: 000C88
- to stream Ncbi, to step Merge: 002D23
- to stream Ncbi, to step Curation: 002D23
Links to Exploration step
pubmed:27774129Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Concise SAR Exploration Based on the "Head-to-Tail" Approach: Discovery of PI4KIIIα Inhibitors Bearing Diverse Scaffolds.</title>
<author><name sortKey="Noji, Satoru" sort="Noji, Satoru" uniqKey="Noji S" first="Satoru" last="Noji">Satoru Noji</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Seki, Noriyoshi" sort="Seki, Noriyoshi" uniqKey="Seki N" first="Noriyoshi" last="Seki">Noriyoshi Seki</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Maeba, Takaki" sort="Maeba, Takaki" uniqKey="Maeba T" first="Takaki" last="Maeba">Takaki Maeba</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sakai, Takayuki" sort="Sakai, Takayuki" uniqKey="Sakai T" first="Takayuki" last="Sakai">Takayuki Sakai</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Watanabe, Eiichi" sort="Watanabe, Eiichi" uniqKey="Watanabe E" first="Eiichi" last="Watanabe">Eiichi Watanabe</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Maeda, Katsuya" sort="Maeda, Katsuya" uniqKey="Maeda K" first="Katsuya" last="Maeda">Katsuya Maeda</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Fukushima, Kyoko" sort="Fukushima, Kyoko" uniqKey="Fukushima K" first="Kyoko" last="Fukushima">Kyoko Fukushima</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Noguchi, Toru" sort="Noguchi, Toru" uniqKey="Noguchi T" first="Toru" last="Noguchi">Toru Noguchi</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ogawa, Kazuya" sort="Ogawa, Kazuya" uniqKey="Ogawa K" first="Kazuya" last="Ogawa">Kazuya Ogawa</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Toyonaga, Yukiyo" sort="Toyonaga, Yukiyo" uniqKey="Toyonaga Y" first="Yukiyo" last="Toyonaga">Yukiyo Toyonaga</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Negoro, Tamotsu" sort="Negoro, Tamotsu" uniqKey="Negoro T" first="Tamotsu" last="Negoro">Tamotsu Negoro</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kawasaki, Hisashi" sort="Kawasaki, Hisashi" uniqKey="Kawasaki H" first="Hisashi" last="Kawasaki">Hisashi Kawasaki</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shiozaki, Makoto" sort="Shiozaki, Makoto" uniqKey="Shiozaki M" first="Makoto" last="Shiozaki">Makoto Shiozaki</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27774129</idno>
<idno type="pmid">27774129</idno>
<idno type="doi">10.1021/acsmedchemlett.6b00232</idno>
<idno type="wicri:Area/PubMed/Corpus">000B98</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000B98</idno>
<idno type="wicri:Area/PubMed/Curation">000B98</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000B98</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000C88</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000C88</idno>
<idno type="wicri:Area/Ncbi/Merge">002D23</idno>
<idno type="wicri:Area/Ncbi/Curation">002D23</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002D23</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Concise SAR Exploration Based on the "Head-to-Tail" Approach: Discovery of PI4KIIIα Inhibitors Bearing Diverse Scaffolds.</title>
<author><name sortKey="Noji, Satoru" sort="Noji, Satoru" uniqKey="Noji S" first="Satoru" last="Noji">Satoru Noji</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Seki, Noriyoshi" sort="Seki, Noriyoshi" uniqKey="Seki N" first="Noriyoshi" last="Seki">Noriyoshi Seki</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Maeba, Takaki" sort="Maeba, Takaki" uniqKey="Maeba T" first="Takaki" last="Maeba">Takaki Maeba</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sakai, Takayuki" sort="Sakai, Takayuki" uniqKey="Sakai T" first="Takayuki" last="Sakai">Takayuki Sakai</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Watanabe, Eiichi" sort="Watanabe, Eiichi" uniqKey="Watanabe E" first="Eiichi" last="Watanabe">Eiichi Watanabe</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Maeda, Katsuya" sort="Maeda, Katsuya" uniqKey="Maeda K" first="Katsuya" last="Maeda">Katsuya Maeda</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Fukushima, Kyoko" sort="Fukushima, Kyoko" uniqKey="Fukushima K" first="Kyoko" last="Fukushima">Kyoko Fukushima</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Noguchi, Toru" sort="Noguchi, Toru" uniqKey="Noguchi T" first="Toru" last="Noguchi">Toru Noguchi</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ogawa, Kazuya" sort="Ogawa, Kazuya" uniqKey="Ogawa K" first="Kazuya" last="Ogawa">Kazuya Ogawa</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Toyonaga, Yukiyo" sort="Toyonaga, Yukiyo" uniqKey="Toyonaga Y" first="Yukiyo" last="Toyonaga">Yukiyo Toyonaga</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Negoro, Tamotsu" sort="Negoro, Tamotsu" uniqKey="Negoro T" first="Tamotsu" last="Negoro">Tamotsu Negoro</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kawasaki, Hisashi" sort="Kawasaki, Hisashi" uniqKey="Kawasaki H" first="Hisashi" last="Kawasaki">Hisashi Kawasaki</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shiozaki, Makoto" sort="Shiozaki, Makoto" uniqKey="Shiozaki M" first="Makoto" last="Shiozaki">Makoto Shiozaki</name>
<affiliation wicri:level="1"><nlm:affiliation>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chemical Research Laboratories, Biological Pharmacological Research Laboratories, and Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125</wicri:regionArea>
<wicri:noRegion>Osaka 569-1125</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">ACS medicinal chemistry letters</title>
<idno type="ISSN">1948-5875</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In typical kinase inhibitor programs, a hinge binder showing best potency with preferential specificity is initially selected, followed by fine-tuning of the accompanying substituents on its core module. A shortcoming of this approach is that the exclusive focus on a single chemotype can endanger all the analogues in the series if a critical shortcoming is revealed. Thus, an early evaluation of structure-activity relationships (SARs) can mitigate unforeseen outcomes within a series of multiple compounds, although there have been very few examples to follow such a policy. PI4KIIIα is one of four mammalian phosphatidylinositol-4 kinases and has recently drawn significant attention as an emerging target for hepatitis C virus (HCV) treatment. In this letter, a novel "head-to-tail" approach to discover a diverse set of PI4KIIIα inhibitors is reported. We believe this method will generate distinct core scaffolds, a rational strategy to circumvent potential risks in general kinase programs.</div>
</front>
</TEI>
<affiliations><list><country><li>Japon</li>
</country>
</list>
<tree><country name="Japon"><noRegion><name sortKey="Noji, Satoru" sort="Noji, Satoru" uniqKey="Noji S" first="Satoru" last="Noji">Satoru Noji</name>
</noRegion>
<name sortKey="Fukushima, Kyoko" sort="Fukushima, Kyoko" uniqKey="Fukushima K" first="Kyoko" last="Fukushima">Kyoko Fukushima</name>
<name sortKey="Kawasaki, Hisashi" sort="Kawasaki, Hisashi" uniqKey="Kawasaki H" first="Hisashi" last="Kawasaki">Hisashi Kawasaki</name>
<name sortKey="Maeba, Takaki" sort="Maeba, Takaki" uniqKey="Maeba T" first="Takaki" last="Maeba">Takaki Maeba</name>
<name sortKey="Maeda, Katsuya" sort="Maeda, Katsuya" uniqKey="Maeda K" first="Katsuya" last="Maeda">Katsuya Maeda</name>
<name sortKey="Negoro, Tamotsu" sort="Negoro, Tamotsu" uniqKey="Negoro T" first="Tamotsu" last="Negoro">Tamotsu Negoro</name>
<name sortKey="Noguchi, Toru" sort="Noguchi, Toru" uniqKey="Noguchi T" first="Toru" last="Noguchi">Toru Noguchi</name>
<name sortKey="Ogawa, Kazuya" sort="Ogawa, Kazuya" uniqKey="Ogawa K" first="Kazuya" last="Ogawa">Kazuya Ogawa</name>
<name sortKey="Sakai, Takayuki" sort="Sakai, Takayuki" uniqKey="Sakai T" first="Takayuki" last="Sakai">Takayuki Sakai</name>
<name sortKey="Seki, Noriyoshi" sort="Seki, Noriyoshi" uniqKey="Seki N" first="Noriyoshi" last="Seki">Noriyoshi Seki</name>
<name sortKey="Shiozaki, Makoto" sort="Shiozaki, Makoto" uniqKey="Shiozaki M" first="Makoto" last="Shiozaki">Makoto Shiozaki</name>
<name sortKey="Toyonaga, Yukiyo" sort="Toyonaga, Yukiyo" uniqKey="Toyonaga Y" first="Yukiyo" last="Toyonaga">Yukiyo Toyonaga</name>
<name sortKey="Watanabe, Eiichi" sort="Watanabe, Eiichi" uniqKey="Watanabe E" first="Eiichi" last="Watanabe">Eiichi Watanabe</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D23 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 002D23 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Ncbi |étape= Checkpoint |type= RBID |clé= pubmed:27774129 |texte= Concise SAR Exploration Based on the "Head-to-Tail" Approach: Discovery of PI4KIIIα Inhibitors Bearing Diverse Scaffolds. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:27774129" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |